HilleVax Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:HLVX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Apr 24	BuyUS$128,325	Frazier Life Sciences Management, LP	Company	8,850	US$14.50
28 Mar 24	BuyUS$21,225	Sean McLoughlin	Individual	1,250	US$16.98
08 Feb 24	SellUS$58,726	Astrid Borkowski	Individual	3,933	US$14.93
08 Feb 24	SellUS$173,161	Robert Hershberg	Individual	11,597	US$14.93
08 Feb 24	SellUS$53,395	Shane Maltbie	Individual	3,576	US$14.93
08 Feb 24	SellUS$132,383	Aditya Kohli	Individual	8,866	US$14.93
15 Dec 23	SellUS$155,000	Astrid Borkowski	Individual	10,000	US$15.50
04 Dec 23	SellUS$287,000	Astrid Borkowski	Individual	20,000	US$14.50
17 Nov 23	SellUS$140,000	Astrid Borkowski	Individual	10,000	US$14.00
08 Nov 23	SellUS$65,000	Astrid Borkowski	Individual	5,000	US$13.00

Insider Buying: HLVX insiders have sold more shares than they have bought in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28%.

Top 25 shareholders own 90.64% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.8%	Frazier Life Sciences Management, LP	8,544,187	US$119.8m	-12.7%	4.86%
14%	Takeda Pharmaceutical Company Limited	6,724,000	US$94.3m	0%	no data
8.32%	Deerfield Management Company, L.P. Series C	4,004,231	US$56.1m	0%	1.04%
6.02%	Deep Track Capital, LP	2,900,000	US$40.7m	0%	1.29%
4.78%	Lightspeed Ventures, LLC	2,303,871	US$32.3m	21%	2.1%
4.31%	VR Adviser, LLC	2,075,000	US$29.1m	1.85%	1.53%
3.83%	Franklin Resources, Inc.	1,846,396	US$25.9m	4.05%	0.01%
3.82%	Abingworth LLP	1,838,486	US$25.8m	0%	6.85%
3.69%	BlackRock, Inc.	1,775,937	US$24.9m	37.9%	no data
3.04%	The Vanguard Group, Inc.	1,464,840	US$20.5m	27%	no data
3.02%	T. Rowe Price Group, Inc.	1,453,790	US$20.4m	1.52%	no data
2.72%	Catalys Pacific	1,308,974	US$18.4m	0%	12.61%
1.72%	StepStone Group LP	826,569	US$11.6m	0%	2.44%
1.69%	Robert Hershberg	812,856	US$11.4m	4.55%	no data
1.66%	Samsara BioCapital LLC	799,274	US$11.2m	0%	2.05%
1.6%	David Socks	769,055	US$10.8m	0%	no data
1.5%	Citadel Advisors LLC	724,376	US$10.2m	-16.5%	0.01%
1.39%	Aditya Kohli	670,779	US$9.4m	-8.9%	no data
1.23%	Geode Capital Management, LLC	591,145	US$8.3m	41.3%	no data
1.16%	Qiming Weichuang Venture Capital Management (Shanghai) Company Limited	558,923	US$7.8m	0%	0.79%
0.94%	Morgan Stanley, Investment Banking and Brokerage Investments	453,017	US$6.4m	-26.1%	no data
0.87%	State Street Global Advisors, Inc.	417,246	US$5.8m	17.2%	no data
0.67%	Acuta Capital Partners, LLC	324,600	US$4.6m	20.1%	2.91%
0.51%	Northern Trust Global Investments	247,673	US$3.5m	43.8%	no data
0.43%	Charles Schwab Investment Management, Inc.	208,773	US$2.9m	0%	no data